Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations.
Two (P117L; M146L) familial Alzheimer's disease (FAD)-causing presenilin-1 (PS1) mutations have been tested fortheir effect in stably transfected mouse neuroblastoma (N2a) cell lines. The P117L mutation is associated with the earliest onset of AD reported so far (24 years), while the M146L is less pathogenic with the onset at about 43 years. Overexpression of wild-type (wt) PS1 gene was associated with the marked increase in the number and the length of neuritic outgrowths accompanied by accumulation of PS1 immunoreactivity in neurites. The highly pathogenic P117L mutation completely suppressed this effect and the pattern of PS1 immunolabeling resembled a cup structure with all immunoreactivity gathered at one pole of the cell. The effect of less pathogenic M146L mutation was similar, but not as pronounced. These findings suggest that one of the normal functions of PS1 may be the control of neurite outgrowth, and the inhibitory effect of two FAD-linked mutations stresses its importance in the cellular mechanism that leads to the development of Alzheimer's disease (AD).
Institute for Basic Research in Developmental Disabilities, Staten Island, New York, NY 10314-6399, USA. karoldow@hotmail.com
W K
WK
Dowjat
T
T
Wisniewski
S
S
Efthimiopoulos
H M
HM
Wisniewski
D000544:Alzheimer Disease / Q000235:genetics*; D000818:Animals; D015153:Blotting, Western; D019084:Fluorescent Antibody Technique, Indirect; D008040:Genetic Linkage / Q000235:genetics*; D006131:Growth Inhibitors / Q000235:genetics* / Q000502:physiology; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics* / Q000502:physiology; D051379:Mice; D009154:Mutation / Q000502:physiology*; D016501:Neurites / Q000502:physiology*; D053764:Presenilin-1; D014407:Tumor Cells, Cultured
D006131:Growth Inhibitors; D008565:Membrane Proteins; C508853:PSEN1 protein, human; D053764:Presenilin-1